Polymerase chain reaction and its uses as a diagnostic tool for cardiovascular disease
1Jeffrey A. Towbin is Associate Professor of Pediatrics (Cardiology) and Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Abstract:
The polymerase chain reaction (PCR), initially developed approximately a decade ago by Kary Mullis, has revolutionized the basic science and clinical research study of human disease. The beauty and utility of this method derive from its simplicity and automation. PCR amplifies a single copy of DNA sequence into millions of identical copies in a matter of hours, allowing rapid detection of subtle differences in sequence, gene cloning, and mutation analysis, among other uses. In this review, the basic technique of PCR and its applications as a diagnostic tool for cardiovascular disease are discussed.
Related Concept Videos
PCR - Polymerase Chain Reaction
PCR
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Real Time RT-PCR
The real-time quantification of the number of amplified products is...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies


